Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |